A safe and efficient 7-week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom.

Christoph SchrautzerLisa Arzt-GradwohlDanijela BokanovicInes SchwarzUrban ČerpesLukas KochSereina Annik HerzogKarin LaipoldBarbara BinderWerner AbererGunter Johannes Sturm

Published in: Allergy (2019)

Keyphrases

randomized controlled trial
reduced graphene oxide
placebo controlled
aqueous solution
clinical trial